NovoCure (NVCR) Common Equity (2014 - 2026)
NovoCure recorded quarterly Common Equity of $330.7 million in Q1 2026, down 2.86% quarter-over-quarter from $340.5 million in Q4 2025, and down 8.63% year-over-year from $362.0 million in Q1 2025.
NovoCure's Common Equity history runs 13 years deep, the most recent figure standing at $330.7 million for Q1 2026.
- In Q1 2026, Common Equity fell 8.63% year-over-year to $330.7 million; the TTM figure through Mar 2026 stood at $330.7 million (down 8.63% YoY), while the FY2025 annual figure was $340.5 million, down 5.47% from the prior year.
- Common Equity came in at $330.7 million for Q1 2026 at NovoCure, down from $340.5 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $445.4 million in Q3 2022 to a low of $330.7 million in Q1 2026.
- A 5-year average of $384.4 million and a median of $362.0 million in 2025 frame the typical range for Common Equity.
- Across the five-year window, Common Equity rose 17.13% in 2022 and fell 17.83% in 2023, its largest moves.
- NovoCure's Common Equity stood at $441.2 million in 2022, then slipped by 17.83% to $362.5 million in 2023, then decreased by 0.64% to $360.2 million in 2024, then dropped by 5.47% to $340.5 million in 2025, then fell by 2.86% to $330.7 million in 2026.
- According to Business Quant data, Common Equity over the past three periods registered $330.7 million, $340.5 million, and $341.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.70 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.98 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 48.99 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 26.10 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.96 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.68 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.20 Bn |
| 10 | NovoCure | 1.90 Bn | 1.47 Bn | 135.13 Mn | 330.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 330.72 Mn |
| Dec 31, 2025 | 340.47 Mn |
| Sep 30, 2025 | 341.33 Mn |
| Jun 30, 2025 | 349.44 Mn |
| Mar 31, 2025 | 361.96 Mn |
| Dec 31, 2024 | 360.18 Mn |
| Sep 30, 2024 | 360.78 Mn |
| Jun 30, 2024 | 361.75 Mn |
| Mar 31, 2024 | 359.36 Mn |
| Dec 31, 2023 | 362.50 Mn |
| Sep 30, 2023 | 393.70 Mn |
| Jun 30, 2023 | 415.68 Mn |
| Mar 31, 2023 | 432.15 Mn |
| Dec 31, 2022 | 441.17 Mn |
| Sep 30, 2022 | 445.40 Mn |
| Jun 30, 2022 | 441.67 Mn |
| Mar 31, 2022 | 435.88 Mn |
| Dec 31, 2021 | 410.49 Mn |
| Sep 30, 2021 | 413.16 Mn |
| Jun 30, 2021 | 397.27 Mn |
| Mar 31, 2021 | 372.13 Mn |
| Dec 31, 2020 | 476.53 Mn |
| Sep 30, 2020 | 307.04 Mn |
| Jun 30, 2020 | 267.82 Mn |
| Mar 31, 2020 | 241.95 Mn |
| Dec 31, 2019 | 217.79 Mn |
| Sep 30, 2019 | 190.37 Mn |
| Jun 30, 2019 | 158.91 Mn |
| Mar 31, 2019 | 126.39 Mn |
| Dec 31, 2018 | 112.26 Mn |
| Sep 30, 2018 | 114.94 Mn |
| Jun 30, 2018 | 112.08 Mn |
| Mar 31, 2018 | 106.12 Mn |
| Dec 31, 2017 | 113.56 Mn |
| Sep 30, 2017 | 116.69 Mn |
| Jun 30, 2017 | 117.55 Mn |
| Mar 31, 2017 | 128.90 Mn |
| Dec 31, 2016 | 142.35 Mn |
| Sep 30, 2016 | 158.24 Mn |
| Jun 30, 2016 | 186.65 Mn |
| Mar 31, 2016 | 220.43 Mn |
| Dec 31, 2015 | 250.82 Mn |
| Sep 30, 2015 | 121.22 Mn |
| Dec 31, 2014 | 97.88 Mn |